Optimize treatment and better advocate for your patients with the Duffy-null phenotype, which lowers normal neutrophil threshold yet is often overlooked in clinical trials. 🎧 Listen now to the new HemeTalks: https://ow.ly/4F9f50XuQuz #Hematology #Hemesky #Medsky #DANC #DuffyNull

🎙️ Just published a new episode of Blood Podcast: Advancing Blood Disorder Treatments Through Precision Therapeutics. Have a listen:

Save the date! 18-20 March 2026 in Rome. Looking forward to this! The International Haemovigilance Symposium is always an excellent and very interactive meeting. More info soon: ihn-org.com

Congratulations, Janne! You've been a wonderful supporter of @lardr.bsky.social and the @bloodsynergy.bsky.social research. We thank you SO MUCH for your contributions!

Thank you so much @isbt.bsky.social! We are so delighted to receive this award! www.systematicreviewinitiative.com/news/we-have... @ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social

Throughout #Telomere Biology Disorder #Awareness Month, we are dedicating Fridays to spreading education and awareness. Each “Fact Friday,” we’ll highlight important science and how ongoing #research connects to care and advocacy. Today we are talking about what #telomeres are - check out our video!

Hope to see many of you at these upcoming @optimal-cre.bsky.social educational events on improving the use of immunoglobulins! Everyone is welcome, and it's free to register. More info below.

Delighted to accept the ISBT Award with Dr Allison Mo on behalf of the ISBT-SRI Transfusion Evidence Round-Up team this week in Perth! @isbt.bsky.social @sritransfusion.bsky.social More info on the Transfusion Evidence Round-Ups: www.isbtweb.org/resources/isbt-sri-transfusion-round-up.html

Fantastic @lardr.bsky.social open meeting today at #BLOOD2025 in collaboration with Lymphoma Australia and the Australasian Lymphoma Alliance. Thanks to everyone who participated in person or online, and for your ongoing support of the Lymphoma and Related Diseases Registry!

Congratulations Dr Jasmine Singh on receiving the 2025 Haematology Society of Australia/NZ Albert Baikie Award, recognising the best Annual Scientific Meeting presentation by a new investigator, for "longitudinal assessment of the expansion of clonal haematopoiesis of indeterminate potential".

Wonderful to be in Perth at #BLOOD2025 and the ISBT regional congress @isbt.bsky.social with some of our Monash University Transfusion Research Unit team. We have presentations, posters and a booth! Have a question about our research, and/or want to collaborate? Come and visit us!

Important new study from the Australian and New Zealand Lymphoma and Related Diseases Registry, out now in Haematologica. doi.org/10.3324/haem... Nice work, Eliza Chung @lardr.bsky.social and @elizahawkes.bsky.social

Out now in JAMA Cardiol: Clonal haematopoiesis of indeterminate potential (CHIP) not associated with higher risk of cardiovascular disease in ASPREE trial, but more clinically significant bleeding. doi:10.1001/jamacardio.2025.3756

➡️ Three major RCTs (HEMOTION, TRAIN, SAHaRA) challenge restrictive transfusion dogma in brain injury. ➡️ Does the evidence now points toward a more liberal, neuroprotective threshold? CCR Journal Watch https://criticalcarereviews.com/latest-evidence/journal-watch

Addressing power gradients (gap between those with the most & least power in a team or system) is THE most effective lever for increasing psychological safety within a team. Many ways to take action for this: psychsafety.com/reducing-pow.... By jadegarratt.bsky.social via tomgeraghty.bsky.social

Somatic preleukemic GATA1s mutations are acquired before birth in 25% of neonates with DS, and are not acquired postnatally. buff.ly/vKCMYCm #hemesky

WiLing Wednesday's Webinars are back! Join us for updates on various MCL topics presented by global experts, starting Oct 29 through to Nov 19. Register on our website : womeninlymphoma.org/webinars First session on Oct 29 : us06web.zoom.us/webinar/regi...

Looking forward to the next International Haemovigilance Network webinar on 21 October: "Partnering with patients is key to safer transfusion" All are welcome, and it's free to register: ihn-org.com/webinars/par...

Great to see the platelet findings from the prospective worldwide InPUT study of transfusion practice in intensive care. Just published in Crit Care Med. doi: 10.1097/CCM.0000000000006880 @bloodsynergy.bsky.social

What is the implication of bulky disease on treatment and outcomes for patients with lymphoma? Read this analysis from the Australasian Lymphoma and Related Diseases Registry @lardr.bsky.social, led by Monash PhD student Eliza Chung. haematologica.org/article/view...

⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry! Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.

Happy to be representing the Australian Haemoglobinopathy Registry at ASCA's 4th Sickle Cell Scientific Conference. 24 October 2025, in person at Perth Children's Hospital, or online. Everyone is welcome! More info/registration: aussicklecelladvocacy.org

🌍 September is Sickle Cell Disease Awareness Month and together we are working to #ConquerSCD! 📚 Identifying pediatric patients with sickle cell disease at high risk of experiencing chronic pain after HSCT 📖 Read the full article here. buff.ly/AgBdW37

Nice work, Dr Sarah Zhao! Aust/NZ Myeloma & Related Diseases Registry real-world comparison of outcomes for older transplant-ineligible pts. Better PFS outcomes for first-line VRd than Rd or VCd. Prospective studies are needed to establish optimal induction therapy. doi: 10.1016/j.clml.2025.08.004

Thanks @who.int for emphasising the importance of preventing and treating non-communicable diseases to improve outcomes for people worldwide

Hope you can join us, in person in Perth, or online, for the Myeloma and Related Diseases Registry annual breakfast meeting, this year on Mon 27 October as part of the Blood/ISBT conference. All are welcome and there is no cost to attend. More info/registration link: www.mrdr.net.au/news/mrdr-an...

📰 New in research: Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors. This important study adds to the growing evidence base on optimizing anticoagulant strategies to reduce recurrence risk: bit.ly/4lZwh7g

Looking forward to the Lymphoma & Related Diseases Registry @lardr.bsky.social annual breakfast meeting at BLOOD! A partnership with Lymphoma Australia and Australasian Lymphoma Alliance. In Perth + online on Tues 28 October. Everyone is welcome! Register: www.eventbrite.com.au/e/alalardrla...

Delighted to report that a new Centre of Research Excellence in supportive care for people with blood cancers (BloodCare) has been funded by the NHMRC! Congratulations to chief investigator, Prof Zoe McQuilten and all our team. Look forward to sharing more as we get started on this important work!

Can sickle red blood cells harm blood vessels without blocking them? Tomorrow’s ASH Journal Club explores how rigidity and altered shear stress spark vascular inflammation. Register now: https://bit.ly/4lbfEFV #HemeSky #MedSky

Most viewed this week from JAMA: Restrictive platelet transfusion strategies are recommended to minimize adverse reactions, mitigate platelet shortages, reduce costs, and ensure patient-centric care. ja.ma/45yYrkQ

NEW: Oxford researchers have discovered an unexpected and powerful new function for platelets. Platelets act as scavengers, capturing and storing fragments of DNA that are circulating in the blood, including fetal DNA and mutated DNA from cancer cells. ⬇️ www.ox.ac.uk/news/2025-08...

Thanks to everyone who joined us, in person and online, for the OPTIMAL Centre of Research Excellence in improving immunoglobulin use workshop and open meeting. Your participation is vital to the work of the CRE! You can find out more about us, and how to get involved, at: www.optimalcre.org

Register for next week's webinar "Infections and Lymphoma - Post-treatment Risk for Infection" with Dr Sairah Ahmed, Dr Mini Kamboj-Gill, Dr Swetha Thiruvengadam, Dr Soni Smith and Dr Florence Broussais-Guillaumot us06web.zoom.us/webinar/regi...

Globally, more than 300 million individuals are living with hepatitis B or C. On #WorldHepatitisDay, explore a @lancetgastrohep.bsky.social Commission examining progress made towards hepatitis elimination & key themes that require further action to meet 2030 targets: tinyurl.com/2eexsumd

OPTIMAL @optimal-cre.bsky.social is an NHMRC Centre of Research Excellence in improving immunoglobulin use. www.optimalcre.org Our open meeting is coming up on Friday 1 August. Everyone is welcome, in person (Melbourne 🇦🇺), or online. More info + registration: 👉 OPTIMALCRE2025.eventbrite.com.au

Hope to see you in Perth for #BLOOD2025 and @isbt.bsky.social in October!

Do infectious agents drive lymphoma initiation? Find out next week during the 3rd webinar of the Pathogens and Lymphoma Series with Catherine Thieblemont, Ayako Arai, Amira Marouf, Florence Broussais-Guillaumot and Sonali Smith Register ➡️ us06web.zoom.us/webinar/regi...

Please join us for this Maddie Riewoldt's Vision online event on Wed 23 July to hear how patients and families can participate in the Aplastic Anaemia & Other Bone Marrow Failure Syndromes Registry and the Australian Marrow Failure Biobank Register at www.mrv.org.au/research/scientific-events

Excited to share our 1st paper from our collaboration with @ianjohnwoolley.bsky.social & Spleen Australia is published! We describe predictors of VZV& shingles vaccine uptake in asplenia. Also a good reminder to all eligible adults to get their shingles vaccine! www.sciencedirect.com/science/arti...

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...

Please join us on Sat 19 July for the OPTIMAL Centre of Research Excellence in improving immunoglobulin use Kawasaki Disease Information Day for clinicians and families. All welcome in person in Melbourne or online! @optimal-cre.bsky.social www.optimalcre.org/events or below for info/registration

What do the rules of war and peace have to do with each other? More than you think. Learn more in this article written by @corduladroege.bsky.social, our chief legal officer, about it 👉🏽 http://ms.spr.ly/63324S2ctY

Our next series of webinars starts next week - register to join live for a presentation by Marie Donzel, Jennifer Amengual, hosted by Florence Broussais, Soni Smith & Amira Marouf Pathogens and Lymphoma - EBV and lymphomagenesis us06web.zoom.us/webinar/regi...

Looking forward to this AAHMS symposium on 9 August! If you are an early-career clinician, researcher or medical/health sciences student, please join us to discuss possibilities & pathways to life as a clinician-scientist! Info/registration: aahms.org/events/life-as-a-clinician-scientist-victoria

Please join us on 1 August for the inaugural open meeting of the OPTIMAL CRE in improving immunoglobulin use! www.optimalcre.org We'll have updates on research projects underway, and lots of opportunities to join the discussion. Registration details below. Everyone is welcome, in person or online!

New WHO recommendations on care for people with sickle cell disease during pregnancy: www.who.int/news/item/19...

On #WorldRefugeeDay, we stand in solidarity with all refugees & reaffirm that … ‘HEALTH IS A HUMAN RIGHT’, not a privilege. Everyone deserves access to safe, dignified, culturally sensitive & affordable care. #HealthForAll 👉 bit.ly/4kQoVDu

💡Honoring the impact & memory of the late Claire McLintock, this @ISTH.org grant supports #ISTHEarlyCareer innovative research in women's health issues in #thrombosis & #hemostasis. Learn more ⬇️and apply by ⏳ Sept. 1! t.co/QYL9cUcoav Thank you to all donors who supported this grant! #ISTH2025

Save the date! Our next webinar series will run throughout July - stay tuned for updates